RALF ROSSKAMP Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RALF ROSSKAMP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RALF ROSSKAMP. RALF ROSSKAMP is EVP, Research & Development in KOS PHARMACEUTICALS INC ($KOSP) and EVP, Research and Development in KOS PHARMACEUTICALS INC ($KOSP) and Chief Medical Officer in Dicerna Pharmaceuticals Inc ($DRNA).
Latest Insider Trading Transactions of RALF ROSSKAMP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 10 2020 | DRNA | Dicerna Pharmaceut ... | ROSSKAMP RALF | Chief Medical Offic ... | Option Exercise | A | 22.58 | 85,000 | 1,919,300 | 85,000 | |
Jan 10 2020 | DRNA | Dicerna Pharmaceut ... | ROSSKAMP RALF | Chief Medical Offic ... | Option Exercise | A | 0.00 | 23,100 | 0 | 23,100 | |
Dec 27 2019 | DRNA | Dicerna Pharmaceut ... | ROSSKAMP RALF | Chief Medical Offic ... | Option Exercise | M | 2.91 | 20,000 | 58,200 | 230,000 | |
Dec 27 2019 | DRNA | Dicerna Pharmaceut ... | ROSSKAMP RALF | Chief Medical Offic ... | Sell | S | 22.69 | 20,000 | 453,764 | 3,564 | 23.6 K to 3.6 K (-84.88 %) |
Dec 27 2019 | DRNA | Dicerna Pharmaceut ... | ROSSKAMP RALF | Chief Medical Offic ... | Buy | M | 2.91 | 20,000 | 58,200 | 23,564 | 3.6 K to 23.6 K (+561.17 %) |
Jan 04 2019 | DRNA | Dicerna Pharmaceut ... | ROSSKAMP RALF | Chief Medical Offic ... | Option Exercise | A | 11.77 | 180,000 | 2,118,600 | 180,000 | |
Jan 08 2018 | DRNA | Dicerna Pharmaceut ... | ROSSKAMP RALF | Chief Medical Offic ... | Option Exercise | A | 9.30 | 57,750 | 537,075 | 57,750 | |
Jun 16 2017 | DRNA | Dicerna Pharmaceut ... | ROSSKAMP RALF | Chief Medical Offic ... | Option Exercise | A | 2.91 | 250,000 | 727,500 | 250,000 | |
Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research and D ... | Option Exercise | D | 44.86 | 19,000 | 852,340 | 0 | |
Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research and D ... | Option Exercise | D | 32.85 | 50,000 | 1,642,500 | 0 | |
Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research and D ... | Option Exercise | D | 50.20 | 27,000 | 1,355,400 | 0 | |
Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research and D ... | Option Exercise | D | 36.84 | 10,000 | 368,400 | 0 | |
Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research and D ... | Option Exercise | D | 35.58 | 10,000 | 355,800 | 0 | |
Dec 15 2006 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research and D ... | Sell | U | 78.00 | 9,818 | 765,804 | 0 | 9.8 K to 0 (-100.00 %) |
Dec 14 2006 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research and D ... | Option Exercise | A | 36.84 | 10,000 | 368,400 | 10,000 | |
Dec 14 2006 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research and D ... | Option Exercise | D | 35.58 | 10,000 | 355,800 | 10,000 | |
Aug 12 2005 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research & Dev ... | Option Exercise | M | 50.20 | 3,000 | 150,600 | 27,000 | |
Aug 12 2005 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research & Dev ... | Option Exercise | M | 35.58 | 7,500 | 266,850 | 32,500 | |
Aug 12 2005 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research & Dev ... | Sell | S | 72.37 | 3,000 | 217,110 | 280 | 3.3 K to 280 (-91.46 %) |
Aug 12 2005 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research & Dev ... | Buy | M | 50.20 | 3,000 | 150,600 | 3,280 | 280 to 3.3 K (+1,071.43 %) |
Aug 12 2005 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research & Dev ... | Sell | S | 72.37 | 7,500 | 542,775 | 280 | 7.8 K to 280 (-96.40 %) |
Aug 12 2005 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research & Dev ... | Buy | M | 35.58 | 7,500 | 266,850 | 7,780 | 280 to 7.8 K (+2,678.57 %) |
Feb 03 2005 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research & Dev ... | Option Exercise | A | 32.85 | 50,000 | 1,642,500 | 50,000 | |
Feb 02 2004 | KOSP | KOS PHARMACEUTICAL ... | ROSSKAMP RALF | EVP, Research and D ... | Option Exercise | A | 50.20 | 30,000 | 1,506,000 | 30,000 |
Page: 1